HIV pre-exposure prophylaxis (PrEP) is a prevention strategy which includes the regular or event-driven use of antiretroviral medication to prevent HIV infection in adults. Several clinical trials ...
Nina T. Harawa ([email protected]), University of California Los Angeles, Los Angeles, California. Diane Tan, University of California Los Angeles. Arleen A. Leibowitz, University of California Los ...
On December 8th, 2021 the CDC released new recommendations for preexposure prophylaxis (PrEP) for the prevention of HIV infection in the US. These new guidelines include important updates designed to ...
A new survey finds that men who would be potential users of HIV pre-exposure prophylaxis (PrEP) medication prefer long-acting injections over pills, but rank side effects and costs as the most ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results